We hypothesized that conjugation of a STING agonist to an albumin binding chaperone would extend blood circulation half-life and increase accumulation in cancerous tissue, enriching the production of cytokines and chemokines that facilitated the recruitment, proliferation, and activation of leukocytes to the TME, which promotes cancer cell death (Fig. 1a). Here, STING1 is linked to cancer.